CLAL Biotechnology Industries Ltd. Logo

CLAL Biotechnology Industries Ltd.

A life sciences VC firm financing and supporting innovative biotech & healthcare ventures.

CBI | TA

Overview

Corporate Details

ISIN(s):
IL0011042806
LEI:
Country:
Israel
Address:
Triangle Building 45th flr., 67023 Tel Aviv
Sector:
Financial and insurance activities
Industry:
Activities of trusts, funds and similar financial entities

Description

Clal Biotechnology Industries Ltd. (CBI) is a leading life sciences investment company and venture capital firm founded in 1998. CBI specializes in identifying, financing, and supporting innovative ventures within the biotechnology and healthcare sectors. Its investment strategy focuses on biopharmaceutical, diagnostic, and medical device companies that develop proprietary solutions to address significant unmet medical needs with high market potential. The firm actively manages its portfolio companies, providing strategic support to foster their growth from early-stage development through to commercialization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-01-08 10:01
Investor Presentation
Corporate Presentation, January 2023
English 3.1 MB
2023-01-08 10:01
Regulatory Filings
Corporate Presentation, January 2023
Russian 41.8 KB
2021-02-14 15:58
Investor Presentation
CBI-Presentation-February 2021
English 2.4 MB
2021-02-14 15:58
Pre-Annual General Meeting Information
CBI-Presentation-February 2021
Russian 43.2 KB
2020-11-22 11:19
Investor Presentation
INVESTORS PRESENTATION,NOVEMBER 10,2020
English 1.9 MB
2020-11-22 11:19
AGM Information
INVESTORS PRESENTATION,NOVEMBER 10,2020
Russian 43.3 KB
2020-08-24 11:54
Investor Presentation
CORPORATE PRESENTATION AUGUST 2020
English 1.7 MB
2020-08-24 11:54
Regulatory Filings
CORPORATE PRESENTATION AUGUST 2020
Russian 43.2 KB

Automate Your Workflow. Get a real-time feed of all CLAL Biotechnology Industries Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CLAL Biotechnology Industries Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CLAL Biotechnology Industries Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Altamir Logo
A listed investment firm providing liquid access to a portfolio of high-growth private companies.
France
LTA
Altrecom PLC Logo
Investment firm using diverse strategies to capitalize on financial market inefficiencies.
Cyprus
ALTR
Altur Investissement Logo
Investment firm providing buyout and growth capital to high-growth, unlisted SMEs.
France
ALTUR
Altus S.A. Logo
Manages investment funds and financial portfolios for diverse clients.
Poland
ALI
Aluma Infrastructure Fund (2020) Ltd. Logo
Invests in shares of high-growth infrastructure firms in telecom, green energy, and environment.
Israel
ALUMA
AMATI AIM VCT PLC Logo
A VCT investing in AIM-listed UK growth firms for retail investors seeking tax-free returns.
United Kingdom
AMAT
Issues ETFs providing investors direct exposure to shipping freight futures markets.
United States of America
BDRY
Angel Oak Financial Strategies Income Term Trust Logo
A term trust investing in U.S. financial institution debt for current income and total return.
United States of America
FINS
Anima Holding Logo
Asset manager providing investment solutions to retail and institutional clients.
Italy
ANIM
ANNALY CAPITAL MANAGEMENT INC Logo
Largest US residential mREIT managing mortgage-backed securities and servicing rights.
United States of America
NLY

Talk to a Data Expert

Have a question? We'll get back to you promptly.